Latest
News

How sequence-based AI achieves whole genome screening for billions of candidates in hours

The platform has been applied across 60+ therapeutic programs, including antibodies, small molecules, cell therapies, siRNA, and synthetic biology applications.

Read More →

NatmolAI™: Computational Expansion and Optimization of Natural-Product Chemical Space

Natural molecules remain a foundational source of bioactive compounds, yet their discovery and optimization are constrained by scarcity and structural complexity.

Read More →

Beauty Engineered: Ainnocence Launches CosmeticAI™ for AI-Driven Innovation in Skincare

CosmeticAI™ shifts early-stage discovery from experimental screening to in silico design, generating large populations of candidate molecules.

Read More →

AI Meets the Formula: Predictive Intelligence Redefines Chemical Design and Manufacturing

Using a formula-centered knowledge graph combined with process-level digital twin simulations, FormulaAI™ predicts formulation stability and compatibility.

Read More →

From Code to Cure: Accelerating Oligonucleotide Design with AI

Oligonucleotide engineering has traditionally been slowed by challenges in sequence selection, immunogenicity, durability, and delivery compatibility.

Read More →

Ainnocence Announces AI Platform for Material Performance Prediction

Material AI operates on the same computational backbone powering Ainnocence's platforms in small molecules, biologics and RNA therapeutics.

Read More →